MIT's CircTrek device revolutionizes health monitoring by detecting individual cells in real-time, promising personalized treatments and improved patient outcomes.
Device can now be used in patients with symptomatic moderate-to-severe or severe mitral regurgitation who are not candidates for surgery or transcatheter edge-to-edge repair therapy.